Literature DB >> 18680232

Risk factors of thrombosis in abdominal veins.

Amit-Kumar Dutta1, Ashok Chacko, Biju George, Joseph Anjilivelil Joseph, Sukesh Chandran Nair, Vikram Mathews.   

Abstract

AIM: To estimate the prevalence of inherited and acquired thrombophilic risk factors in patients with abdominal venous thrombosis and to compare the risk factor profiles between Budd-Chiari syndromes (BCS) and splanchnic vein thrombosis (SVT).
METHODS: In this retrospective study, 36 patients with abdominal venous thrombosis were studied. The patients were divided into Budd-Chiari group (hepatic vein, IVC thrombosis) and splanchnic venous thrombosis group (portal, splenic, superior mesenteric veins) based on the veins involved. Hereditary and acquired thrombophilic risk factors were evaluated in all patients.
RESULTS: Twenty patients had SVT, 14 had BCS, and 2 had mixed venous thrombosis. Ten patients (28%) had hereditary and 10 patients (28%) acquired thrombophilic risk factors. The acquired risk factors were significantly more common in the SVT group (SVT vs BCS: 45% vs 7%, c2 = 5.7, P = 0.02) while hereditary risk factors did not show significant differences between the two groups (SVT vs BCS: 25% vs 36%, c2 = 0.46, P = 0.7). Multiple risk factors were present in one (7%) patient with BCS and in 3 patients (15%) with SVT. No risk factors were identified in 57% of patients with BCS and in 45% of patients with SVT.
CONCLUSION: Hereditary and acquired risk factors play an important role in the etiopathogenesis of abdominal venous thrombosis. Acquired risk factors are significantly more common in SVT patients while hereditary factors are similar in both groups.

Entities:  

Mesh:

Year:  2008        PMID: 18680232      PMCID: PMC2731279          DOI: 10.3748/wjg.14.4518

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Population genetics of factor V Leiden in Europe.

Authors:  G Lucotte; G Mercier
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

Review 2.  Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.

Authors:  G Espinosa; J Font; J C García-Pagan; D Tàssies; J C Reverter; C Gaig; F Cervantes; R Cervera; J Bosch; M Ingelmo
Journal:  Medicine (Baltimore)       Date:  2001-11       Impact factor: 1.889

Review 3.  Acquired thrombophilic syndromes.

Authors:  D Matei; B Brenner; V J Marder
Journal:  Blood Rev       Date:  2001-03       Impact factor: 8.250

4.  The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.

Authors:  T Egesel; Y Büyükasik; S V Dündar; A Gürgey; S Kirazli; Y Bayraktar
Journal:  J Clin Gastroenterol       Date:  2000-01       Impact factor: 3.062

5.  Factor V Leiden related Budd-Chiari syndrome.

Authors:  P Deltenre; M H Denninger; S Hillaire; M C Guillin; N Casadevall; J Brière; S Erlinger; D C Valla
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

6.  Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.

Authors:  B Hirshberg; D Shouval; E Fibach; G Friedman; D Ben-Yehuda
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

7.  Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Authors:  H L Janssen; J R Meinardi; F P Vleggaar; S H van Uum; E B Haagsma; F J van Der Meer; J van Hattum; R A Chamuleau; R P Adang; J P Vandenbroucke; B van Hoek; F R Rosendaal
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

Review 8.  Thrombophilia in pregnancy.

Authors:  I D Walker
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

9.  Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.

Authors:  D Mohanty; S Shetty; K Ghosh; A Pawar; P Abraham
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 10.  Genetic risk factors of venous thrombosis.

Authors:  R F Franco; P H Reitsma
Journal:  Hum Genet       Date:  2001-10       Impact factor: 4.132

View more
  6 in total

1.  Islet autotransplantation in a patient with hypercoagulable disorder.

Authors:  Chirag S Desai; Khalid M Khan; Wanxing Cui
Journal:  World J Transplant       Date:  2016-06-24

2.  Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Adults with Splanchnic Vein Thrombosis: A Case-Control Study.

Authors:  Arpitha Kollabathula; Saniya Sharma; Narender Kumar; Jasmina Ahluwalia; Reena Das; Neelam Varma; Surinder Singh Rana
Journal:  Indian J Hematol Blood Transfus       Date:  2021-06-18       Impact factor: 0.900

Review 3.  Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment.

Authors:  Francesca R Ponziani; Maria A Zocco; Chiara Campanale; Emanuele Rinninella; Annalisa Tortora; Luca Di Maurizio; Giuseppe Bombardieri; Raimondo De Cristofaro; Anna M De Gaetano; Raffaele Landolfi; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

Review 4.  Management of acute post-operative portal venous thrombosis.

Authors:  Ryan M Thomas; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2009-07-07       Impact factor: 3.452

5.  Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population.

Authors:  Mario D'Amico; Pietro Sammarco; Linda Pasta
Journal:  Int J Vasc Med       Date:  2013-12-18

6.  Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt.

Authors:  Muhamad R Abdel Hameed; Esam Abdel-Moneim Sadek Elbeih; Heba Mahmoud Abd El-Aziz; Ola Abdel-Haleem Afifi; Lamiaa Mohammed Refaat Khalaf; Mohammed Zakaria Ali Abu Rahma; Abeer Sabry
Journal:  J Blood Med       Date:  2020-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.